Screener
AbCellera Biologics Inc. ABCL Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|
| Depreciation of property and equipment | 8,951 | 11,977 |
| Amortization of intangible assets | 1,851 | 1,851 |
| Amortization of operating lease right-of-use assets | 2,863 | 3,610 |
| Stock-based compensation | 28,993 | 24,299 |
| Other | 70 | 7,019 |
| Changes in operating assets and liabilities: | ||
| Research fees and grants receivable | (12,524) | 25,367 |
| Income taxes receivable | (7,588) | (8,024) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s compensation and benefits?
- AbCellera Biologics Inc. (ABCL) reported compensation and benefits of $12.29M in Q2 2026.
- How has AbCellera Biologics Inc.'s compensation and benefits changed year-over-year?
- AbCellera Biologics Inc.'s compensation and benefits decreased by 13.5% year-over-year, from $14.21M to $12.29M.
- What is the long-term trend for AbCellera Biologics Inc.'s compensation and benefits?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s compensation and benefits has grown at a -6.8% compound annual growth rate (CAGR), from $64.18M to $55.79M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about AbCellera Biologics Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude